Blackstone Inc
ASMB icon

Blackstone Inc’s Assembly Biosciences ASMB Stock Holding History

Blackstone Inc’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.24M Sell
296,855
-21,899
-7% -$625K 0.03% 88
2025
Q4 		$10.8M Sell
318,754
-129,035
-29% -$4.16M 0.04% 92
2025
Q3 		$11.5M Buy
+447,789
New +$9.82M 0.05% 91

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Blackstone Inc's ASMB Position: Q1 2026 in Review

Blackstone Inc reduced its Assembly Biosciences (ASMB) stake by 6.9% in Q1 2026, selling an estimated $625K and leaving 296,855 shares worth $8.24M. The position accounts for 0.03% of the portfolio, ranked #88.

Blackstone Inc first reported a position in ASMB in Q3 2025 and has held it in 3 quarters since. The position peaked at $11.5M in Q3 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Blackstone Inc held 296,855 shares of Assembly Biosciences worth $8.24M as of Q1 2026.
  • Blackstone Inc sold 21,899 Assembly Biosciences shares in Q1 2026, an estimated $625K.
  • Assembly Biosciences made up 0.03% of Blackstone Inc's portfolio in Q1 2026, its #88 holding.
  • Blackstone Inc first reported a position in Assembly Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Blackstone Inc's Assembly Biosciences position peaked at $11.5M in Q3 2025.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Blackstone Inc's 13F filing for Q1 2026, filed 15 May 2026.